Biotech Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting December 8, 2024
Biotech Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting December 8, 2024
Biotech UCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting December 7, 2024
Biotech Caliway Biopharmaceuticals Included in FTSE TWSE Taiwan Eight Industries and Mid-Cap 100 Indices December 7, 2024
Biotech 3DBIOLABS ACHIEVES PIVOTAL MILESTONE IN DEVELOPMENT OF 3D PRINTED LIVER IMPLANT December 6, 2024
Biotech WuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP Authorizations December 6, 2024
Biotech Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patents in Australia and Singapore December 5, 2024
Biotech Ariceum Therapeutics and Eckert & Ziegler Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments December 5, 2024
Biotech Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications December 4, 2024